Systemic inflammatory disorders such as Acute Respiratory Distress Syndrome (ARDS), vasculitis, sepsis, and acute cytokine release syndrome (CRS) induced by CAR-T therapies are associated with increased plasma levels of inflammatory stimuli such as cytokines TNFα and IFNγ.1 The gene discussed is IFNG; the disease is acute respiratory distress syndrome.